A PPAR-gamma agonist protects from radiation-induced intestinal toxicity

OBJECTIVE: Because of its anti-inflammatory, anti-fibrotic, anti-apoptotic and anti-neoplastic properties, the PPAR-γ agonist rosiglitazone is an interesting drug for investigating for use in the prevention and treatment of radiation-induced intestinal damage. We aimed to evaluate the radioprotectiv...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:United European Gastroenterol J
Prif Awduron: Mangoni, Monica, Sottili, Mariangela, Gerini, Chiara, Desideri, Isacco, Bastida, Cinzia, Pallotta, Stefania, Castiglione, Francesca, Bonomo, Pierluigi, Meattini, Icro, Greto, Daniela, Cappelli, Sabrina, Di Brina, Lucia, Loi, Mauro, Biti, Giampaolo, Livi, Lorenzo
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: SAGE Publications 2016
Pynciau:
Original Articles
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5349355/
https://ncbi.nlm.nih.gov/pubmed/28344789
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640616640443
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg